AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 50 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $49,000 | +8.9% | 83,869 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $45,000 | -40.0% | 83,869 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $75,000 | -7.4% | 83,869 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $81,000 | +5.2% | 83,869 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $77,000 | -27.4% | 83,869 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $106,000 | +5.0% | 83,869 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $101,000 | -29.4% | 83,869 | +1.9% | 0.00% | -25.0% |
| Q2 2015 | $143,000 | +11.7% | 82,292 | -6.7% | 0.00% | 0.0% |
| Q1 2015 | $128,000 | +73.0% | 88,219 | 0.0% | 0.00% | +33.3% |
| Q4 2014 | $74,000 | -32.7% | 88,219 | -11.2% | 0.00% | -25.0% |
| Q3 2014 | $110,000 | -43.6% | 99,319 | -6.9% | 0.00% | -42.9% |
| Q2 2014 | $195,000 | +21.9% | 106,701 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $160,000 | -20.0% | 106,701 | -2.2% | 0.01% | -30.0% |
| Q4 2013 | $200,000 | -28.1% | 109,101 | -2.0% | 0.01% | -52.4% |
| Q2 2013 | $278,000 | – | 111,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 20,896,038 | $33,434,000 | 1.33% |
| X-Square Capital, LLC | 270,680 | $433,000 | 0.34% |
| Granahan Investment Management | 2,508,261 | $4,013,000 | 0.28% |
| 683 Capital Management, LLC | 1,875,000 | $3,000,000 | 0.18% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $643,000 | 0.18% |
| Caption Management, LLC | 855,000 | $1,366,000 | 0.11% |
| Private Portfolio Partners LLC | 51,000 | $82,000 | 0.05% |
| Evercore Wealth Management, LLC | 418,414 | $669,000 | 0.02% |
| Fosun International Ltd | 206,491 | $335,000 | 0.02% |
| EXCALIBUR MANAGEMENT CORP | 11,000 | $18,000 | 0.02% |